Company profile

Navignostics AG

Our mission is to identify the ideal treatment to battle each cancer patient's disease and reduce suffering throughout their journey. At Navignostics we characterize tumors using spatial single-cell proteomics. We use our unique capabilities to identify a cancer treatment that will optimally fight each patient's tumor. We also accelerate cancer drug development by providing key insights into drug mechanisms and tumor features for companion diagnostic development. Our highly robust and reliable technology and our leading data analytics position us ideally to enable precision cancer diagnostics for patients and to provide services to pharma and biotech partners. This way we help people suffering from cancer by making more drugs available and by finding the right one for every patient.

More news about Navignostics AG

19.02.2024 11:00

Companies worldwide embrace digitalisation with Swiss startups

Please login or
register to use the
awards follow feature
19.04.2023 11:20

Ten biotech startups head to Boston

Please login or
register to use the
awards follow feature
11.11.2022 15:00

Navignostics raises CHF 7.5M to advance precision cancer medicine

Please login or
register to use the
awards follow feature
02.09.2022 15:35

UZH Life Science Fund invests in Navignostics

Please login or
register to use the
awards follow feature
Navignostics AG

Founded
2022

Kanton
ZH


LinkedIn

Homepage

rss